Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

Health and Healthcare

Merck : MRK

All Merck Articles

1079 Articles

Chris Lange | Dec 12, 2018 at 9:50 AM EST

Major Pharma Stocks See a Surge in Short Interest

The November 30 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Dec 8, 2018 at 7:20 AM EST

Major Health Care Catalysts Coming by the End of 2018

24/7 Wall St. takes a look at what is coming up in the FDA calendar regarding biotech and pharmaceutical companies…

Chris Lange | Nov 28, 2018 at 9:00 AM EST

Short Sellers Hike Their Bets in Major Pharma Stocks

The November 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Nov 12, 2018 at 10:10 AM EST

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

The October 31 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Nov 12, 2018 at 6:50 AM EST

The 6 Most Shorted NYSE Stocks

Judging by the most shorted stocks traded on the New York Stock Exchange between the October 15 and October 31…

Paul Ausick | Nov 3, 2018 at 8:04 AM EDT

Merck Takes Over as Dow’s Top-Performing Dow Stock

Drugmaker Merck wrestled away from Apple the top ranking last week as the best performing stock among the Dow 30.

Paul Ausick | Nov 2, 2018 at 4:01 PM EDT

Apple, Intel Tank the Dow Friday

Apple, Intel, Pfizer, and Merck were the worst performing Dow stocks on Friday.

Chris Lange | Oct 31, 2018 at 10:55 AM EDT

Merck Wins Yet Again With New Keytruda Approval

Merck shares were up slightly on Wednesday after the pharma giant gave another key update for its KEYTRUDA line. The…

Douglas A. McIntyre | Oct 31, 2018 at 6:50 AM EDT

Dow Stars Apple and Merck Up Over 25%

Many market experts worry that poor earnings and a slowing economy could beat down the market between now and the…

Lee Jackson | Oct 27, 2018 at 9:55 AM EDT

5 Stocks to Move to Now If You Fear a Total Market Crash

What makes sense for investors now is safe stocks that pay dividends and provide products or services that will continue…

Paul Ausick | Oct 27, 2018 at 8:40 AM EDT

Apple Retains Grip as Top-Performing Dow Stock

Apple returns for another week as the top-performing Dow stock for the year to date even though shares dropped nearly…

Chris Lange | Oct 25, 2018 at 9:00 AM EDT

Major Pharma Short Sellers Hike Their Bets

The October 15 short interest data have been compared with the previous figures, and short interest in most of these…

Paul Ausick | Oct 25, 2018 at 8:25 AM EDT

Merck Earnings Reflect Huge Increase in Keytruda Sales, Outlook Raised for FY18

Pharmaceutical maker Merck beat adjusted earnings estimates but missed slightly on revenues when it reported Q3 results Thursday morning. Investors…

Lee Jackson | Oct 25, 2018 at 7:10 AM EDT

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

These four top pharmaceutical companies have longstanding franchises with huge sales and revenues, and their dividend-paying stocks look like outstanding choices…

Chris Lange | Oct 21, 2018 at 10:25 AM EDT

McDonald’s, Merck, Microsoft and More Dow Stocks Reporting This Week

24/7 Wall St. has put together a preview of Boeing, Intel, Verizon and the other Dow companies scheduled to report…

1 … 18 19 20 21 22 … 72

Merck : MRK

All Merck Articles

Major Pharma Stocks See a Surge in Short Interest

Major Health Care Catalysts Coming by the End of 2018

Short Sellers Hike Their Bets in Major Pharma Stocks

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

The 6 Most Shorted NYSE Stocks

Merck Takes Over as Dow’s Top-Performing Dow Stock

Apple, Intel Tank the Dow Friday

Merck Wins Yet Again With New Keytruda Approval

Dow Stars Apple and Merck Up Over 25%

5 Stocks to Move to Now If You Fear a Total Market Crash

Apple Retains Grip as Top-Performing Dow Stock

Major Pharma Short Sellers Hike Their Bets

Merck Earnings Reflect Huge Increase in Keytruda Sales, Outlook Raised for FY18

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

McDonald’s, Merck, Microsoft and More Dow Stocks Reporting This Week

Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

3 Dividend Stocks Built for Retirement to Buy in June

From PC Maker to AI Giant: How Dell Rewarded Patient Investors With Nearly 1,900% Gains and AI Capex Determines The Future

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

3 Dividend Stocks Built for Retirement to Buy in June

From PC Maker to AI Giant: How Dell Rewarded Patient Investors With Nearly 1,900% Gains and AI Capex Determines The Future

Merck : MRK

All Merck Articles

Major Pharma Stocks See a Surge in Short Interest

Major Health Care Catalysts Coming by the End of 2018

Short Sellers Hike Their Bets in Major Pharma Stocks

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

The 6 Most Shorted NYSE Stocks

Merck Takes Over as Dow’s Top-Performing Dow Stock

Apple, Intel Tank the Dow Friday

Merck Wins Yet Again With New Keytruda Approval

Dow Stars Apple and Merck Up Over 25%

5 Stocks to Move to Now If You Fear a Total Market Crash

Apple Retains Grip as Top-Performing Dow Stock

Major Pharma Short Sellers Hike Their Bets

Merck Earnings Reflect Huge Increase in Keytruda Sales, Outlook Raised for FY18

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

McDonald’s, Merck, Microsoft and More Dow Stocks Reporting This Week

Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

3 Dividend Stocks Built for Retirement to Buy in June

From PC Maker to AI Giant: How Dell Rewarded Patient Investors With Nearly 1,900% Gains and AI Capex Determines The Future

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation